Literature DB >> 1570184

[Detection of Toxoplasma gondii by "Polymerase Chain Reaction" (PCR) technique in AIDS infected patients using the repetitive sequence TGR1E].

N Cristina1, F Derouin, H Pelloux, R Pierce, M F Cesbron-Delauwn, P Ambroise-Thomas.   

Abstract

A repetitive original DNA sequence, TGR1E, was cloned and sequenced, then used to develop a polymerase chain reaction (PCR) test for detecting Toxoplasma gondii. Preliminary studies were performed using purified T. gondii DNA or a lysate of purified T. gondii cells [7], with or without a leukocyte lysate. A negative correlation was evidenced between sensitivity of the test and the amount of cellular debris contaminating the DNA to be amplified. Nevertheless, the method was tested on 100 clinical specimens subjected to lysis using the same method. Among the 88 specimens from AIDS patients, four were positive by conventional diagnostic tests and by PCR. Among the 12 specimens tested as part of evaluations for the prevention of congenital toxoplasmosis, PCR failed to detect the positive results yielded by conventional tests on two amniotic fluid specimens. No false positive result was seen with the PCR method.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570184

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  10 in total

1.  Detection of Toxoplasma gondii in cerebrospinal fluid from AIDS patients by polymerase chain reaction.

Authors:  S F Parmley; F D Goebel; J S Remington
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Limited value of PCR for detection of Toxoplasma gondii in blood from human immunodeficiency virus-infected patients.

Authors:  C Franzen; M Altfeld; P Hegener; P Hartmann; G Arendt; H Jablonowski; J Rockstroh; V Diehl; B Salzberger; G Fätkenheuer
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Screening for active toxoplasmosis in patients by DNA hybridization with the ABGTg7 probe in blood samples.

Authors:  S O Angel; M Matrajt; J Margarit; M Nigro; E Illescas; V Pszenny; M R Amendoeira; E Guarnera; J C Garberi
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

Review 4.  Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation.

Authors:  Rashad Abdul-Ghani
Journal:  Parasitol Res       Date:  2011-01-11       Impact factor: 2.289

5.  Urine sample used for congenital toxoplasmosis diagnosis by PCR.

Authors:  I Fuentes; M Rodriguez; C J Domingo; F del Castillo; T Juncosa; J Alvar
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

6.  Detection of Toxoplasma gondii in AIDS patients by the polymerase chain reaction.

Authors:  N Cristina; H Pelloux; C Goulhot; J P Brion; P Leclercq; P Ambroise-Thomas
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

7.  Detection of the pathogenic parasite Toxoplasma gondii by specific amplification of ribosomal sequences using comultiplex polymerase chain reaction.

Authors:  J M Guay; D Dubois; M J Morency; S Gagnon; J Mercier; R C Levesque
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction.

Authors:  J Dupouy-Camet; S L de Souza; C Maslo; A Paugam; A G Saimot; R Benarous; C Tourte-Schaefer; F Derouin
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

9.  Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients.

Authors:  M Dupon; J Cazenave; J L Pellegrin; J M Ragnaud; A Cheyrou; I Fischer; B Leng; J Y Lacut
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes.

Authors:  Udo Reischl; Stéphane Bretagne; Dominique Krüger; Pauline Ernault; Jean-Marc Costa
Journal:  BMC Infect Dis       Date:  2003-05-02       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.